Matt Abernethy - 29 May 2025 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role: Director
Signature: /s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol: FATE
Transactions as of: 29 May 2025
Net transactions value: $0
Form type: 4
Filing time: 30 May 2025, 16:06:10 UTC
Previous filing: 14 Feb 2025
Next filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ABERNETHY MATT	Director	C/O FATE THERAPEUTICS, INC., 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO	/s/ Cindy R. Tahl, as Attorney-in-Fact	30 May 2025	0001724097

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FATE	Stock Option (Right to Buy)	Award	$0	+110,000		$0.000000	110,000	29 May 2025	Common Stock	110,000	$1.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest in 36 equal monthly installments following May 29, 2025, such that all of the shares shall be fully vested and exercisable on May 29, 2028, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.